<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC6835697\results\search\drugs\results.xml">
  <result pre="(Table 3) [26,28,29,32]. GRFT showed synergistic antiviral activity with tenofovir," exact="maraviroc" post="(a CCR5 antagonist), and enfuvirtide (a gp41 fusion peptide"/>
  <result pre="synergistic antiviral activity with tenofovir, maraviroc (a CCR5 antagonist), and" exact="enfuvirtide" post="(a gp41 fusion peptide inhibitor) [29]. The different glycosylation"/>
  <result pre="Rev. Drug Discov.2003262463410.1038/nrd115112904812 7.Abdool KarimQ.Abdool KarimS.S.FrohlichJ.A.GroblerA.C.BaxterC.MansoorL.E.KharsanyA.B.SibekoS.MlisanaK.P.OmarZ.et al.Effectiveness and safety of" exact="tenofovir" post="gel, an antiretroviral microbicide, for the prevention of HIV"/>
  <result pre="Retroviruses2012281513152310.1089/aid.2012.002622607556 29.FerirG.PalmerK.E.ScholsD.Synergistic activity profile of griffithsin in combination with tenofovir," exact="maraviroc" post="and enfuvirtide against HIV-1 clade cVirology201141725325810.1016/j.virol.2011.07.00421802104 30.HoorelbekeB.XueJ.LiWangP.J.BalzariniJ.Role of the"/>
  <result pre="activity profile of griffithsin in combination with tenofovir, maraviroc and" exact="enfuvirtide" post="against HIV-1 clade cVirology201141725325810.1016/j.virol.2011.07.00421802104 30.HoorelbekeB.XueJ.LiWangP.J.BalzariniJ.Role of the carbohydrate-binding sites"/>
  <result pre="MT-4 cells p24 HIV-1 core Ag ELISA Tenofovir, maraviroc, and" exact="enfuvirtide" post="Synergy [29] HeLa-ADA effector cells and HeLa-P5L CCR5-bearing target"/>
  <result pre="target T cells Giant cell formation Efavirenz, tenofovir, raltegravir, and" exact="elvitegravir" post="Synergy [28] Raji.DC-SIGN cells DC-SIGN mediated HIV transmission Tenofovir,"/>
 </snippets>
</snippetsTree>
